Subscribe to Newsletter

Specific Detection of Inflammation Markers with Tissue Context Using RNAscope® Technology

Detection of Immune Biomarkers in the Tissue

Introduction

Understanding molecular mechanisms is critical for identifying pathogenesis, evaluating disease progression and developing new therapeutic strategies for autoimmunity, infectious diseases, and cancer. RNAscope® in situ hybridization (ISH) technology enables precise cell- and tissue-specific localization of RNA transcripts. With RNAscope® ISH assays, you can detect specifically expressed immune markers in lymphoid and non-lymphoid tissues while maintaining the morphological context. For example, RNAscope® chromogenic in situ hybridization (CISH) robustly identified the expression pattern of CD274 mRNA in formalin-fixed paraffin-embedded (FFPE) kidney cancer tissue (Figure 1).

Read the full article now

Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE!

Login
Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register